Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | T-cell metabolism: a novel therapeutic avenue for GvHD

Nataliya Buxbaum, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY, talks on the important role of T-cells in graft-versus-host disease (GvHD). Recent experiments have shown that the T-cells mediating GvHD are glycolytic when entering target organs, which suggests metabolic therapy as a promising strategy to treat GvHD. In addition, this will enable imaging metabolic processes in vivo with MRI. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.